GlassScriptPhysician profile
Miriam Sivkin
NPI 1578624474
$1,910.49
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $86.75 · 2021: $118 · 2022: $501 · 2023: $423 · 2024: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $421.26 | 2019-2024 | Slynd |
| Abbvie INC. | $401.94 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Allergan, INC. | $169.31 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $147.02 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.25 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $115.04 | 2023-2024 | Gemtesa |
| Exact Sciences Corporation | $103.05 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $101.56 | 2019 | |
| Astellas Pharma US INC | $89.76 | 2019-2024 | Veozah |
| Urovant Sciences INC | $71.76 | 2022 | |
| Therapeuticsmd, INC. | $49.53 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $37.62 | 2023-2024 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $25.14 | 2021 | |
| Convatec INC. | $19.46 | 2024 | |
| Amag Pharmaceuticals, INC. | $18.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $12.85 | 2022 | |
| Agile Therapeutics, INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miriam Sivkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.